Yurova KА, Melashchenko ES, Khaziakhmatova OG, Malashchenko VV, Melashchenko OB, Shunkin EO, et al. Osteogenic Differentiation Factors of Multipotent Mesenchymal Stromal Cells in the Current Understanding. Curr Pharm Des 2021; 27(35): 3741-3751. doi: 10.2174/1381612827666210406150027.
Chan WCW, Tan Z, To MKT, Chan D. Regulation and Role of Transcription Factors in Osteogenesis. Int J Mol Sci 2021; 22(11):5445. doi: 10.3390/ijms22115445
Yang H, editor. Osteogenesis and Bone Regeneration. Intech Open 2019. Available from: doi:10.5772/intechopen.73955
Xu L, Liu Y, Sun Y, Wang B, Xiong Y, Lin W, et al. Tissue source determines the differentiation potentials of mesenchymal stem cells: a comparative study of human mesenchymal stem cells from bone marrow and adipose tissue. Stem Cell Res Ther 2017; 8(1): 275. doi: 10.1186/s13287-017-0716-x.
Caplan AI. Mesenchymal stem cells. J Orthop Res 1991; 9: 641–650.
Dawson JI, Kanczler J, Tare R, Kassem M, Oreffo RO. Concise review: bridging the gap: bone regeneration using skeletal stem cell-based strategies - where are we now? Stem Cells 2014; 32(1): 35-44.
Short B, Brouard N, Occhiodoro-Scott T, Ramakrishnan A, Simmons PJ. Mesenchymal stem cells. Arch Med Res 2003; 34(6): 565–71. doi:10.1016/j.arcmed.2003.09.007
Lee YC, Chan YH, Hsieh SC, Lew WZ, Feng SW. Comparing the Osteogenic Potentials and Bone Regeneration Capacities of Bone Marrow and Dental Pulp Mesenchymal Stem Cells in a Rabbit Calvarial Bone Defect Model. Int J Mol Sci 2019; 20(20): 5015.
Park JC, Oh SY, Lee JS, Park SY, Choi EY, Cho KS,et al. In vivo bone formation by human alveolar-bone-derived mesenchymal stem cells obtained during implant osteotomy using biphasic calcium phosphate ceramics or Bio-Oss as carriers. J Biomed Mater Res B Appl Biomater 2016; 104(3): 515-24.
Kunkel N, Wagner A, Gehwolf R, Heimel P, Tempfer H, Korntner S, et al. Comparing the osteogenic potential of bone marrow and tendon-derived stromal cells to repair a critical-sized defect in the rat femur. J Tissue Eng Regen Med 2017; 11(7): 2014-2023.
Yu, B.H, Zhou, Q, Wang, Z.L. Periodontal ligament versus bone marrow mesenchymal stem cells in combination with Bio-Oss scaffolds for ectopic and in situ bone formation: A comparative study in the rat. J Biomater Appl 2014, 29, 243–253.
Xun J, Li C, Liu M, Mei Y, Zhou Q, Wu B, et al. Serum exosomes from young rats improve the reduced osteogenic differentiation of BMSCs in aged rats with osteoporosis after fatigue loading in vivo. Stem Cell Res Ther. 2021; 12(1): 424.
Capulli M, Paone R, Rucci N. Osteoblast and osteocyte: games without frontiers. Arch Biochem Biophys 2014; 561: 3–12.
Fu Y, Karbaat L, Wu L, Leijten J, Both SK, Karperien
M. Trophic effects of mesenchymal stem cells in tissue regeneration. Tissue Eng Part B Rev 2017; 23(6): 515–28.
Baraniak PR, McDevitt TC. Stem cell paracrine actions and tissue regeneration. Regen Med 2010, 5, 121–143.
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8(4): 315-7.
Fonseca LN, Bolívar-Moná S, Agudelo T, Beltrán LD, Camargo D, Correa N, et al. Cell surface markers for mesenchymal stem cells related to the skeletal system: A scoping review. Heliyon. 2023; 9(2): e13464.
Ghaneialvar H, Soltani L, Rahmani HR, Lotfi AS, Soleimani M. Characterization and Classification of Mesenchymal Stem Cells in Several Species Using Surface Markers for Cell Therapy Purposes. Indian J Clin Biochem 2018;33(1):46-52. doi: 10.1007/s12291-017-0641-x.
Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, et al. Novel regulators of bone formation: molecular clones and activities. Science 1988; 242(4885): 1528-34.
Hemmati-Brivanlou A, Thomsen GH. Ventral mesodermal patterning in Xenopus embryos: expression patterns and activities of BMP-2 and BMP-4. Dev Genet 1995;17(1):78–89.
Bodine PV, Zhao W, Kharode YP, Bex FJ, Lambert AJ, Goad MB, et al. The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol Endocrinol 2004;18(5):1222-37.
Li X, Zhang Y, Kang H, Liu W, Liu P, Zhang J, et al. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J Biol Chem 2005;280(20):19883-7.
Ponzetti M, Rucci N. Osteoblast Differentiation and Signaling: Established Concepts and Emerging Topics. Int J Mol Sci 2021;22(13):6651.
Wagner EF. Functions of AP1 (Fos/Jun) in bone development. Ann Rheum Dis 2002;61 (Suppl 2):ii40-2.
Marie PJ. Transcription factors controlling osteo blas-togenesis. Arch Biochem Biophys. 2008; 473(2): 98-105.
Kim J-M, Lin C, Stavre Z, Greenblatt MB, Shim
J- H. Osteoblast-Osteoclast Communication and Bone Homeostasis. Cells 2020; 9(9):2073.
Bonewald LF. Osteocytes. In: Marcus and Feldman’s Osteoporosis. Elsevier. 2021. pp. 135–63.
Robling AG, Castillo AB, Turner CH. Biomechanical and molecular regulation of bone remodeling. Annu Rev Biomed Eng 2006;8(1):455–98.
Wiktor-Jedrzejczak W, Bartocci A, Ferrante AW Jr, Ahmed-Ansari A, Sell KW, Pollard JW, et al. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci USA 1990;87(12):4828-32.
Nakashima T, Hayashi M, Fukunaga T, Kurata K, Oh-Hora M, Feng JQ, et al. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med 2011;17(10):1231-4.
Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999;397(6717):315-23. doi: 10.1038/16852.
Mizuno A, Kanno T, Hoshi M, Shibata O, Yano K, Fujise N, et al. Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosis. J Bone Miner Metab 2002;20(6):337-44. doi: 10.1007/s007740200049.
Lala R, De Sanctis C. Pamidronate treatment of bone fibrous dysplasia in nine children with McCune-Albright sindrome. Acta Paediatr 2000;89(2):188–93.
Hofbauer LC, Schoppet M. Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA 2004;292(4):490–5.
Nardone V, D’Asta F, Brandi ML. Pharmacological management of osteogenesis. Clinics (Sao Paulo) 2014;69(6):438–46.
Yang S, Zhang Y, Rodriguiz RM, Ries WL, Key LL Jr. Functions of the M-CSF receptor on osteoclasts. Bone 1996; 18(4): 355–60.
Email this article (Login required) 
